Clinical Trials Browser

Phase 2 × cc-486 × Plasma cell × Clear all

NCT04174196 2025-12-02

A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma

Phase 2 Active not recruiting

Multiple Myeloma, Plasmacytoma